Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.34 – $2.86
55% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.3M | $20.6M | $24.4M | $24.5M | $28.9M | $25.2M | $37.4M | $42.3M |
| Cost of revenue | $18.0M | $15.8M | $17.4M | $18.2M | $20.1M | $18.1M | $27.4M | $29.7M |
| Gross profit | $6.4M | $4.9M | $7.0M | $6.2M | $8.8M | $7.0M | $10.1M | $12.6M |
| Gross margin | 26.2% | 23.6% | 28.8% | 25.5% | 30.4% | 27.9% | 26.9% | 29.7% |
| R&D | $271.5K | $46.5K | $30.5K | $14.2K | $97.1K | $30.4K | $43.9K | $48.1K |
| Operating income | $1.7M | −$1.0M | $2.7M | $2.1M | $2.6M | $3.1M | $4.3M | $6.6M |
| EBITDA | $1.3M | −$814.2K | $3.1M | $2.7M | $3.0M | $3.4M | $4.8M | $7.0M |
| Net income | $4.7M | −$1.3M | $2.1M | $1.3M | $1.6M | $2.2M | $3.0M | $4.8M |
| Net margin | 19.2% | -6.3% | 8.6% | 5.3% | 5.6% | 8.7% | 8.1% | 11.4% |
| EPS (diluted) | 0.12 | -0.03 | 0.05 | 0.03 | 0.09 | 0.13 | 0.16 | 0.26 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $48M | $0.30 | $0.30–$0.30 | 1 |
Forward consensus · source: Financial Modeling Prep
BIOREM INC
No one on the platform currently holds BIRMF.
No tracked institution reports a position in BIRMF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2005-01-21 | 1-for-4reverse |
No one on the platform has traded BIRMF yet.
| $30M |
| — |
| CVATCavitation Technologies, Inc. | $0.03 | -15.31% | $8M | — |
| GRNWFGreenlane Renewables Inc. | $0.13 | +0.00% | $20M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 18.6× earnings vs its 6.6× historical median P/E.
Fair value ≈ $0.77 · price $2.18 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.